Search review questions

Diarrhoea (3 liquid stools in a single day) (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age

Respiratory infections (as measured by trialists) (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age

All‐cause death (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age

Infection or inflammation at individual level as measured by C‐reactive protein (CRP) (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age

Anaemia (defined as haemoglobin below WHO cut‐off for age and adjusted for altitude as appropriate) · general population of all age groups (including pregnant women) from any country, over two years of age

Iron deficiency (as defined by study authors, based on a biomarker of iron status) · general population of all age groups (including pregnant women) from any country, over two years of age

Primary outcomes · Older adults living independently in the community

Sedentary time · Older adults living independently in the community

Secondary outcomes · Older adults living independently in the community

Physical function · Older adults living independently in the community

Waist circumference · Older adults living independently in the community

Systolic blood pressure · Older adults living independently in the community

Diastolic blood pressure · Older adults living independently in the community

Level of glucose in blood · Older adults living independently in the community

Adverse effects · Older adults living independently in the community

Health behaviours · adults

Body function · adults

Well‐being Outcomes ‐ General well‐being and Quality of life · adults

Psychological outcomes ‐ Distress and Depression · adults

Adverse events · adults

Total daily moderate‐to‐vigorous physical activity (MVPA) · health problem or population

Proportion of care session spent in MVPA (% session spent in MVPA) · health problem or population

Cardiovascular fitness (3‐minute endurance test) · health problem or population

Cost‐effectiveness · health problem or population

Adverse outcomes ‐ not reported · health problem or population

Quality of life ‐ not reported · health problem or population

Number or proportion of cases in the community

Epidemic growth acceleration

Exportation growth rate

No contributing study

Number or proportion of cases exported

Time to outbreak

Risk of outbreak

Number or proportion of cases detected

Proportion of cases detected

Positive predictive value (PPV)

Proportion of secondary cases

Number or proportion of imported or exported cases

Proportion of imported cases

No contributing study.

Days at risk of transmitting the infection into the community

Probability of releasing an infected individual into the community

Outcome category: cases avoided due to the measure

Number or proportion of cases in the community

Proportion of imported cases

Number or proportion of cases seeded by imported cases

Probability of an imported case not infecting anyone

Time to outbreak

Number or proportion of deaths

Days at risk of transmitting the infection into the community